Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2252271-93-3
2. Unii-i1yqt8hc89
3. I1yqt8hc89
4. 4-(3,3-difluoro-2,2-dimethylpropanoyl)-3,5-dihydro-2h-pyrido(3,4-f)(1,4)oxazepine-9-carbonitrile
5. 4-(3,3-difluoro-2,2-dimethylpropanoyl)-3,5-dihydro-2h-pyrido[3,4-f][1,4]oxazepine-9-carbonitrile
6. Pyrido(3,4-f)-1,4-oxazepine-9-carbonitrile, 4-(3,3-difluoro-2,2-dimethyl-1-oxopropyl)-2,3,4,5-tetrahydro-
7. Oditrasertib [inn]
8. Oditrasertib (usan/inn)
9. Chembl5314474
10. Schembl20564972
11. Gtpl12372
12. Csclqchkuamzoy-uhfffaoysa-n
13. Bdbm529953
14. Glxc-27896
15. Ex-a8863
16. Us11203600, Example 29
17. Da-56386
18. Example 29 [wo2018213632a1]
19. Hy-148787
20. Cs-0641059
21. D12940
22. G87144
23. 4-(3,3-difluoro-2,2- Dimethyl- Propanoyl)-3,5- Dihydro-2h- Pyrido[3,4-f] [1,4]oxazepine-9- Carbonitrile
24. 4-(3,3-difluoro-2,2-dimethylpropanoyl)-2,3,4,5- Tetrahydropyrido[3,4-f][1,4]oxazepine-9-carbonitrile
| Molecular Weight | 295.28 g/mol |
|---|---|
| Molecular Formula | C14H15F2N3O2 |
| XLogP3 | 1.3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 2 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 66.2 |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 447 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
81
PharmaCompass offers a list of Oditrasertib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oditrasertib manufacturer or Oditrasertib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oditrasertib manufacturer or Oditrasertib supplier.
PharmaCompass also assists you with knowing the Oditrasertib API Price utilized in the formulation of products. Oditrasertib API Price is not always fixed or binding as the Oditrasertib Price is obtained through a variety of data sources. The Oditrasertib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oditrasertib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oditrasertib, including repackagers and relabelers. The FDA regulates Oditrasertib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oditrasertib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Oditrasertib supplier is an individual or a company that provides Oditrasertib active pharmaceutical ingredient (API) or Oditrasertib finished formulations upon request. The Oditrasertib suppliers may include Oditrasertib API manufacturers, exporters, distributors and traders.
Oditrasertib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oditrasertib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oditrasertib GMP manufacturer or Oditrasertib GMP API supplier for your needs.
A Oditrasertib CoA (Certificate of Analysis) is a formal document that attests to Oditrasertib's compliance with Oditrasertib specifications and serves as a tool for batch-level quality control.
Oditrasertib CoA mostly includes findings from lab analyses of a specific batch. For each Oditrasertib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oditrasertib may be tested according to a variety of international standards, such as European Pharmacopoeia (Oditrasertib EP), Oditrasertib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oditrasertib USP).
